ALK-Abello A/S Sustainability Reports
ALK-Abelló A/S is a global specialty pharmaceutical company focused on allergy immunotherapy treatments. The company develops, produces, and markets a diversified portfolio of products for diagnosing and treating respiratory allergies and severe allergic reactions.
Sector: Manufacturing
Country: Denmark
Exchange: Nasdaq Copenhagen
ISIN: DK0060027142
28 reports from 2005 to 2025